Characteristics of Graves' Disease in Children and Adolescents in Nanjing: A Retrospective Investigation Study

Overview

Journal Front Public Health

Specialty Public Health

Date 2022 Oct 28

PMID 36304250

Authors

Hang Xie

Dandan Chen

Ju Zhang

Ruize Yang

Wei Gu

Xu Wang

Affiliations

Soon will be listed here.

Abstract

Objective: This cross-sectional study analyzed the clinical characteristics of newly diagnosed Graves' disease (GD) in children and adolescents to provide clinical evidence for the early diagnosis of GD.

Method: From 2013 to 2019, information on children and adolescents with newly diagnosed GD admitted to the Department of Endocrinology, Children's Hospital of Nanjing Medical University, was collected, including clinical features and laboratory tests. The data were summarized and statistically analyzed.

Result: This study included 204 cases of newly diagnosed GD, with 158 females and 46 males. The average age at initial diagnosis was 8.9 ± 2.9 years. A total of 132 cases (64.7%) had symptoms before puberty, and 72 cases (35.3%) had symptoms during puberty. Goiter was detected in 193 cases (94.6%). There were 140 cases (68.6%) of exophthalmos, and 21.4% (30/140) were infiltrative. At initial diagnosis, 10 cases (4.9%) reported leukopenia, 18 cases (8.8%) reported neutropenia, and 15 cases (7.4%) reported mild anemia. There was 1 (0.5%) case of thrombocytopenia and 1 (0.5%) case of agranulocytosis. Fifty-four cases (26.5%) had impaired liver function.

Conclusion: GD is more common in female children and adolescents. Parents may ignore their children's hypermetabolic symptoms in the early stages of GD. Routine blood and liver function tests are recommended at initial diagnosis to exclude abnormal hemogram and liver function.

Citing Articles

Effect of methimazole treatment on Th1, Th17, and Th22 lymphocytes in pediatric Graves' disease patients.

Starosz A, Stozek K, Opechowska A, Bossowski F, Moniuszko M, Grubczak K Front Immunol. 2024; 15:1431686.

PMID: 39439793 PMC: 11494814. DOI: 10.3389/fimmu.2024.1431686.

Diagnosis of Graves' Disease and Methimazole-Induced Lupus Erythematosus in an Adolescent Male During the COVID-19 Era: A Case Report.

Kumar T, White A Cureus. 2024; 16(6):e62023.

PMID: 38989384 PMC: 11233457. DOI: 10.7759/cureus.62023.

Functional enrichment analysis of mutated genes in children with hyperthyroidism.

Mao X, Tang L, Li H, Zhang W, Liu L, Wang H Front Endocrinol (Lausanne). 2023; 14:1213465.

PMID: 37876543 PMC: 10591315. DOI: 10.3389/fendo.2023.1213465.

Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease.

Steffens B, Koch G, Gachter P, Claude F, Gotta V, Bachmann F Front Med (Lausanne). 2023; 10:1099470.

PMID: 37206476 PMC: 10188966. DOI: 10.3389/fmed.2023.1099470.

References

Chen W, Man N, Li Y, Shan Z, Teng W . [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Zhonghua Nei Ke Za Zhi. 2006; 45(2):95-9. View

Smith T, Hegedus L . Graves' Disease. N Engl J Med. 2016; 375(16):1552-1565. DOI: 10.1056/NEJMra1510030. View

Gruneiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich J . Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab. 2004; 16(9):1249-55. DOI: 10.1515/jpem.2003.16.9.1249. View

Lin M, Hsu F, Bee Y, Ger L . Age influences the severity of Graves' ophthalmopathy. Kaohsiung J Med Sci. 2008; 24(6):283-8. DOI: 10.1016/S1607-551X(08)70154-2. View

Holt H, Hunter D, Smith J, Dagi L . Pediatric Graves' ophthalmopathy: the pre- and postpubertal experience. J AAPOS. 2008; 12(4):357-60. DOI: 10.1016/j.jaapos.2007.12.011. View

Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F . The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study. J Endocrinol Invest. 2016; 39(12):1445-1451. DOI: 10.1007/s40618-016-0516-7. View

Leger J, Gelwane G, Kaguelidou F, Benmerad M, Alberti C . Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study. J Clin Endocrinol Metab. 2011; 97(1):110-9. DOI: 10.1210/jc.2011-1944. View

Biscoveanu M, Hasinski S . Abnormal results of liver function tests in patients with Graves' disease. Endocr Pract. 2001; 6(5):367-9. DOI: 10.4158/EP.6.5.367. View

Aggarwal N, Tee S, Saqib W, Fretwell T, Summerfield G, Razvi S . Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease. Clin Endocrinol (Oxf). 2016; 85(6):949-953. DOI: 10.1111/cen.13133. View

10.

Gastaldi R, Poggi E, Mussa A, Weber G, Vigone M, Salerno M . Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers. J Pediatr. 2014; 164(5):1189-1194.e1. DOI: 10.1016/j.jpeds.2013.12.047. View

11.

Mazo D, De Vasconcelos G, Pereira M, de Mello E, Bacchella T, Carrilho F . Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism. Clin Exp Gastroenterol. 2013; 6:9-17. PMC: 3579408. DOI: 10.2147/CEG.S39358. View

12.

Yuan S, Yu N, Gao Y, Huang W, He Y, Dong B . [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis]. Zhonghua Yi Xue Za Zhi. 2014; 94(2):110-4. View

13.

Kaguelidou F, Alberti C, Castanet M, Guitteny M, Czernichow P, Leger J . Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab. 2008; 93(10):3817-26. DOI: 10.1210/jc.2008-0842. View

14.

Moulton V . Sex Hormones in Acquired Immunity and Autoimmune Disease. Front Immunol. 2018; 9:2279. PMC: 6180207. DOI: 10.3389/fimmu.2018.02279. View

15.

Yang F, Teng W, Shan Z, Guan H, Li Y, Jin Y . Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidism. Eur J Endocrinol. 2002; 146(5):613-8. DOI: 10.1530/eje.0.1460613. View

16.

Wang R, Tan J, Zhang G, Zheng W, Li C . Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment. Medicine (Baltimore). 2017; 96(5):e6035. PMC: 5293474. DOI: 10.1097/MD.0000000000006035. View

17.

Brix T, Hegedus L . Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf). 2011; 76(4):457-64. DOI: 10.1111/j.1365-2265.2011.04318.x. View

18.

Litao M, Gutierrez Alvarez A, Shah B . Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism. J Clin Res Pediatr Endocrinol. 2020; 13(3):263-268. PMC: 8388046. DOI: 10.4274/jcrpe.galenos.2020.2020.0184. View

19.

Zophel K, Roggenbuck D, Schott M . Clinical review about TRAb assay's history. Autoimmun Rev. 2010; 9(10):695-700. DOI: 10.1016/j.autrev.2010.05.021. View

20.

Markle J, Frank D, Mortin-Toth S, Robertson C, Feazel L, Rolle-Kampczyk U . Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013; 339(6123):1084-8. DOI: 10.1126/science.1233521. View